guaifenesin has been researched along with Sarcoidosis, Pulmonary in 1 studies
Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
Sarcoidosis, Pulmonary: Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reichenberger, F | 1 |
| Kleiber, B | 1 |
| Baschiera, B | 1 |
| Bubendorf, L | 1 |
| Brutsche, M | 1 |
| Dalquen, P | 1 |
| Tamm, M | 1 |
1 other study available for guaifenesin and Sarcoidosis, Pulmonary
| Article | Year |
|---|---|
Bronchoalveolar lavage quality influences the T4/T8 ratio in sarcoidosis.
Topics: Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; CD4-CD8 Ratio; Cell Count; Cilia; Female; Huma | 2007 |